Pathogenic bacteria

There is no end to humankind’s fight against infectious diseases, which can be life-threatening and significantly reduce quality of life in later life. However, it can be difficult for university researchers and companies to obtain pathogenic bacteria to study pathogenic mechanisms, develop therapeutic and diagnostic agents, and examine the pathogenic bacteria themselves. The NBRP conserves and provides a wide variety of pathogenic bacteria for research purposes.

Stock

・Pathogenic bacteria that cause opportunistic infection; biosafety level 3; class II, III, and IV pathogens under the Infectious Diseases Control Law; non-pathogenic bacteria related to these pathogens: about 4,800 strains
・Human enteropathogenic bacteria including Vibrio parahaemolyticus, V. cholerae, and Shiga toxin-producing Escherichia coli (about 12,000 strains in total): 1,286 strains

Subjects in the NBRP programs “Genome information upgrading program” and “Fundamental technology upgrading program” related to “Pathogenic bacteria”

【 Fundamental technology upgrading program 】